1. ICH Q3A(R2) Impurities in New Drug Substances (Step 4 version), (n.d.). https://www.pmda.go.jp/files/000246300.pdf (accessed August 21, 2022).
2. ICH Q3B(R2) Impurities in New Drug Products (Step 4 version), (n.d.). https://www.pmda.go.jp/files/000246300.pdf (accessed August 21, 2022).
3. ICH Q3C(R8) Guideline for Residual Solvents(Step 4 version), (n.d.). https://www.pmda.go.jp/files/000246300.pdf (accessed August 21, 2022).
4. ICH Q3D Guideline For Elemental Impurities (Final version), (n.d.). https://www.pmda.go.jp/files/000246300.pdf (accessed November 4, 2022).
5. Drug-like properties and the causes of poor solubility and poor permeability;Lipinski;J. Pharmacol. Toxicol. Methods,2000